Search research articles
Contact Us
Filters
Showing results (51-60 of 287) with videos related to
Page
of 29
Sort By:
The Journal of Thoracic and Cardiovascular Surgery
|
August 1, 1991
Reply to invited letter concerning: neonatal aortic stenosis. The balloon deflated? (J Thorac Cardiovasc Surg 1990;100:927-89)
K Turley, J J Amato, E L Bove
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Estramustine in combination with vinblastine and mitomycin-C for patients with progressive androgen independent adenocarcinoma of the prostate
R J Amato, C Bui, C J Logothetis
Clinical Genitourinary Cancer
|
December 16, 2011
Phase I trial of everolimus plus sorafenib for patients with advanced renal cell cancer
Robert J Amato, Amber L Flaherty, Mika Stepankiw
Urologic Oncology
|
March 28, 2008
Phase 2 study of granulocyte-macrophage colony-stimulating factor plus thalidomide in patients with hormone-naïve adenocarcinoma of the prostate
Robert J Amato, Joan Hernandez-McClain, Haby Henary
Chemical Research in Toxicology
|
April 8, 2017
Replicative Bypass Studies of α-Anomeric Lesions of 2'-Deoxyribonucleosides in Vitro
Nicole L Williams, Nicholas J Amato, Yinsheng Wang
The Annals of Thoracic Surgery
|
February 1, 1995
Single-stage repair of thoracic ectopia cordis
J J Amato, J Zelen, N G Talwalkar
AORN Journal
|
June 30, 2012
Perfecting patient flow in the surgical setting
Elaine J Amato-Vealey, Patricia Fountain, Deborah Coppola
Ohio Medicine : Journal of the Ohio State Medical Association
|
April 1, 1989
Transrectal ultrasound used in office practice to aid in the diagnosis of carcinoma of the prostate
H W Riemenschneider, L C Galdieri, J Amato
Anti-Cancer Drugs
|
April 18, 2008
Interferon-alpha in combination with either imatinib (Gleevec) or gefitinib (Iressa) in metastatic renal cell carcinoma: a phase II trial
Robert J Amato, Jaroslaw Jac, Joan Hernandez-McClain
Cancer
|
May 11, 2001
The association between treatment-specific optimism and depressive symptomatology in patients enrolled in a Phase I cancer clinical trial
L Cohen, C de Moor, R J Amato
Page
of 29
Search research articles
Search
Showing results (51-60 of 287) with videos related to
Sort By:
Page
of 29
The Journal of Thoracic and Cardiovascular Surgery
|
August 1, 1991
Reply to invited letter concerning: neonatal aortic stenosis. The balloon deflated? (J Thorac Cardiovasc Surg 1990;100:927-89)
K Turley, J J Amato, E L Bove
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Estramustine in combination with vinblastine and mitomycin-C for patients with progressive androgen independent adenocarcinoma of the prostate
R J Amato, C Bui, C J Logothetis
Clinical Genitourinary Cancer
|
December 16, 2011
Phase I trial of everolimus plus sorafenib for patients with advanced renal cell cancer
Robert J Amato, Amber L Flaherty, Mika Stepankiw
Urologic Oncology
|
March 28, 2008
Phase 2 study of granulocyte-macrophage colony-stimulating factor plus thalidomide in patients with hormone-naïve adenocarcinoma of the prostate
Robert J Amato, Joan Hernandez-McClain, Haby Henary
Chemical Research in Toxicology
|
April 8, 2017
Replicative Bypass Studies of α-Anomeric Lesions of 2'-Deoxyribonucleosides in Vitro
Nicole L Williams, Nicholas J Amato, Yinsheng Wang
The Annals of Thoracic Surgery
|
February 1, 1995
Single-stage repair of thoracic ectopia cordis
J J Amato, J Zelen, N G Talwalkar
AORN Journal
|
June 30, 2012
Perfecting patient flow in the surgical setting
Elaine J Amato-Vealey, Patricia Fountain, Deborah Coppola
Ohio Medicine : Journal of the Ohio State Medical Association
|
April 1, 1989
Transrectal ultrasound used in office practice to aid in the diagnosis of carcinoma of the prostate
H W Riemenschneider, L C Galdieri, J Amato
Anti-Cancer Drugs
|
April 18, 2008
Interferon-alpha in combination with either imatinib (Gleevec) or gefitinib (Iressa) in metastatic renal cell carcinoma: a phase II trial
Robert J Amato, Jaroslaw Jac, Joan Hernandez-McClain
Cancer
|
May 11, 2001
The association between treatment-specific optimism and depressive symptomatology in patients enrolled in a Phase I cancer clinical trial
L Cohen, C de Moor, R J Amato
Page
of 29